Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca's SGLT2 inhibitor Forxiga, after NICE backed NHS use of the drug in draft ...

and means that Boehringer and Lilly can now compete head to head across all three indications with AstraZeneca's Forxiga (dapagliflozin). AZ's drug was approved for CKD in the EU and US in 2021 ...

The government has defended its negotiations with AstraZeneca, after the pharmaceutical giant ditched a planned £450m investment last week, blaming a shortfall in government funding. Science ...

UK drugmaker AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter of 2024.

AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales of cancer drugs helped lift revenues higher. The FTSE 100-listed drugmaker said ...

In celebrations to mark World Cancer Day 2025, AstraZeneca reaffirmed its commitment to advancing early detection, innovative treatments, and holistic patient care under this year’s theme ...

Strong performances by AstraZeneca and mining stocks today helped the FTSE 100 index set a new record above 8700. The rise of 1% came as the Bank of England prepared to announce another interest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WILMINGTON, Del., January 27, 2025--AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the US for the treatment of adult patients with unresectable ...

Lord Storey formerly served as leader of Liverpool City Council A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca pulled ...